🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Endymed (ENDY)

Tel Aviv
Currency in ILS
297.8
0.0(0.00%)
Delayed Data
ENDY Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
297.8297.8
52 wk Range
190.0355.0
Key Statistics
Edit
Bid/Ask
290.40 / 299.60
Prev. Close
297.8
Open
297.8
Day's Range
297.8-297.8
52 wk Range
190-355
Volume
1
Average Volume (3m)
15.22K
1-Year Change
-6.94%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ENDY Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Endymed Company Profile

Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Its products comprise EndyMed PRO, a multi-application treatment platform; PURE 2.0 that offers professional skin tightening, body contouring, and functional resurfacing; and 3DEEP radiofrequency technology, a solution for the treatment of skin tightening, wrinkle reduction, RF micro needling, and fractional skin resurfacing. The company was incorporated in 2004 and is based in Freehold, New Jersey.

Compare ENDY to Peers and Sector

Metrics to compare
ENDY
Peers
Sector
Relationship
P/E Ratio
−6.3x−2.9x−0.6x
PEG Ratio
0.020.000.00
Price/Book
0.9x3.9x2.6x
Price / LTM Sales
0.6x2.2x3.2x
Upside (Analyst Target)
-31.9%46.2%
Fair Value Upside
Unlock10.0%7.0%Unlock

FAQ

What Is the Endymed (ENDY) Stock Price Today?

The Endymed stock price today is 297.80

What Stock Exchange Does Endymed Trade On?

Endymed is listed and trades on the Tel Aviv stock exchange.

What Is the Stock Symbol for Endymed?

The stock symbol for Endymed is "ENDY."

What Is the Endymed Market Cap?

As of today, Endymed market cap is 40.98M.

What is Endymed Earnings Per Share?

The Endymed EPS is -0.133.

From a Technical Analysis Perspective, Is ENDY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.